VIGABATRIN is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa, Inc.. The primary component is Vigabatrin.
| Product ID | 69097-964_1f961c15-53a5-493c-a8d1-527f9eb8a4c2 |
| NDC | 69097-964 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VIGABATRIN |
| Generic Name | Vigabatrin |
| Dosage Form | Powder, For Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-12-04 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211592 |
| Labeler Name | Cipla USA, Inc. |
| Substance Name | VIGABATRIN |
| Active Ingredient Strength | 500 mg/mL |
| Pharm Classes | Anti-epileptic Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-12-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA211592 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-12-04 |
| Ingredient | Strength |
|---|---|
| VIGABATRIN | 500 mg/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0652 | Vigabatrin | Vigabatrin |
| 0574-0201 | VIGABATRIN | vigabatrin |
| 0574-0470 | VIGABATRIN | vigabatrin |
| 0591-3851 | Vigabatrin | Vigabatrin |
| 0591-3955 | vigabatrin | vigabatrin |
| 16729-521 | Vigabatrin | Vigabatrin |
| 42799-950 | Vigabatrin | Vigabatrin |
| 43598-651 | Vigabatrin | Vigabatrin |
| 43598-697 | Vigabatrin | Vigabatrin |
| 49884-358 | VIGABATRIN | vigabatrin |
| 59651-366 | Vigabatrin | Vigabatrin |
| 59651-367 | Vigabatrin | Vigabatrin |
| 64850-940 | Vigabatrin | vigabatrin |
| 69238-1425 | Vigabatrin | Vigabatrin |
| 69097-964 | VIGABATRIN | VIGABATRIN |
| 67877-674 | VIGABATRIN | VIGABATRIN |
| 67386-111 | SABRIL | vigabatrin |
| 67386-211 | SABRIL | vigabatrin |
| 31722-009 | vigabatrin for oral solution | vigabatrin |
| 0054-0702 | Vigabatrin for oral solution USP, 500 mg | Vigabatrin |
| 0245-0556 | VIGADRONE | vigabatrin |